Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

Journal of Experimental Medicine

Volumn 203, Issue 7, 2006, Pages 1693-1700

  Seddiki, Nabila ^a,b,c   Santner Nanan, Brigitte ^d   Martinson, Jeff ^e   Zaunders, John ^b   Sasson, Sarah ^b   Landay, Alan ^e   Solomon, Michael ^f   Selby, Warwick ^f   Alexander, Stephen I ^g   Nanan, Ralph ^d   Kelleher, Anthony ^b,c   De St Groth, Barbara Fazekas ^a  

^a University of Sydney   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; BLOOD; CD25+ T LYMPHOCYTE; CELL SURFACE; FLOW CYTOMETRY; HUMAN; LYMPH NODE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; HUMANS; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; RECEPTORS, INTERLEUKIN-2; RECEPTORS, INTERLEUKIN-7; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 33745813929     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060468     Document Type: Article

References (29)

1. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531-562.
2. + regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. 199:1285-1291.
3. Crispin, J.C., A. Martinez, and J. Alcocer-Varela. 2003. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 21:273-276.
4. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 6:R335-R346.
5. Ehrenstein, M.R., J.G. Evans, A. Singh, S. Moore, G. Warnes, D.A. Isenberg, and C. Mauri. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200:277-285.
6. high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 174:164-173.
7. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199:971-979.
8. + regulatory T cells in patients with Kawasaki disease. J. Pediatr. 145:385-390.
9. + regulatory T cells in children who have outgrown cow's milk allergy. J. Exp. Med. 199:1679-1688.
10. + regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet. 363:608-615.
11. Ochs, H.D., S.F. Ziegler, and T.R. Torgerson. 2005. FOXP3 acts as a rheostat of the immune response. Immunol. Rev. 203:156-164.
12. Kukreja, A., G. Cost, J. Marker, C. Zhang, Z. Sun, K. Lin-Su, S. Ten, M. Sanz, M. Exley, B. Wilson, et al. 2002. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109:131-140.
13. - T cells in myasthenia gravis and in relation to thymectomy. Scand. J. Immunol. 59:408-414.
14. + T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J. Clin. Immunol. 24:155-161.
15. + regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 50:2775-2785.
16. high regulatory cells in human peripheral blood. J. Immunol. 167:1245-1253.
17. + regulatory T cells in adult life. Blood. 107:2830-2838.
18. + regulatory T cells at the single-cell level. Eur. J. Immunol. 35:1681-1691.
19. + regulatory T cells in inflamed synovia. J. Exp. Med. 201:1793-1803.
20. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A.C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:253-261.
21. von Freeden-Jeffry, U., P. Vieira, L.A. Lucian, T. McNeil, S.E. Burdach, and R. Murray. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519-1526.
22. +-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood. 105:750-758.
23. Valmori, D., A. Merlo, N. Souleimania, C. Hesdorffer, and M. Ayyoub. 2005. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 115:1953-1962.
24. Baecher-Allan, C., E. Wolf, and D.A. Hafler. 2006. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176:4622-4631.
25. + T regulatory cells in humans. Hum. Immunol. 66:13-20.
26. Allan, S.E., L. Passerini, R. Bacchetta, N. Crellin, M. Dai, P.C. Orban, S.F. Ziegler, M.G. Roncarolo, and M.K. Levings. 2005. The role of 2 FOXP3 isoforms in the generation of human CD4 Tregs. J. Clin. Invest. 115:3276-3284.
27. + suppressor T cells in vivo. Nat. Immunol. 3:33-41.
28. + regulatory T cells. J. Immunol. 171:5678-5682.
29. Cupedo, T., M. Nagasawa, K. Weijer, B. Blom, and H. Spits. 2005. Development and activation of regulatory T cells in the human fetus. Eur. J. Immunol. 35:383-390.